Yun Ho Bio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Yun Ho Bio - overview
Established
2022
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Founded in January 2022 and based in Suzhou, China, Yun Ho Bio is a biotechnology company specializing in medical research and pharmaceutical development. In August 2025, Yun Ho Bio raised a series A funding led by Ennovation Ventures. The company’s core business includes medical research and experimental development, excluding human stem cell and gene diagnosis and treatment technologies. It also offers a range of technical services such as technology development, consulting, exchange, transfer, and promotion, supporting the innovation and application of pharmaceutical technologies.
Yun Ho Bio primarily generates revenue through its research and development projects in medicine combined with comprehensive technical services related to medical technology.
Current Investors
Ennovation Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Biotechnology, Pharmaceuticals, Pharmaceutical Research & Development
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.